Ankara Universitesi Teknokent
🇹🇷Turkey
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision
Phase 3
Completed
- Conditions
- Retinitis Pigmentosa
- Interventions
- Device: MagnovisionBiological: Wharton's jelly derived mesenchymal stemcells
- First Posted Date
- 2023-04-05
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- Ankara Universitesi Teknokent
- Target Recruit Count
- 80
- Registration Number
- NCT05800301
- Locations
- 🇹🇷
BioRetina, Ankara, Gölbaşı, Turkey
🇹🇷Ankara University Biotechnology Institute, Ankara, Türkiye, Turkey
🇹🇷Umut Arslan, Ankara, Turkey
Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation
Phase 3
Completed
- Conditions
- Toxic Optic NeuropathyMagnetic Field ExposureStem Cell Tyrosine Kinase 1 Y842XMethanol Poisoning
- Interventions
- Biological: Wharton jelly derived mesenchymal stem cellDevice: Repetitive electromagnetic stimulation
- First Posted Date
- 2021-05-07
- Last Posted Date
- 2021-05-10
- Lead Sponsor
- Ankara Universitesi Teknokent
- Target Recruit Count
- 18
- Registration Number
- NCT04877067
- Locations
- 🇹🇷
Umut Arslan, Ankara, Turkey
🇹🇷Ankara University Biotechnology Institute, Ankara, Türkiye, Turkey
Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma
Not Applicable
Completed
- Conditions
- Retinitis Pigmentosa
- Interventions
- Combination Product: PRP combined MagnovisionBiological: PRP
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Ankara Universitesi Teknokent
- Target Recruit Count
- 60
- Registration Number
- NCT04252534
Management of Deep Retinal Capillary Ischemia by Electromagnetic Stimulation and Platelet- Rich Plasma
Not Applicable
Completed
- Conditions
- Paracentral Acute Middle MaculopathyAcute Macular NeuroretinopathyDeep Retinal Capillary Ischemia
- Interventions
- Device: Electromagnetic stimulationBiological: Platelet rich plasma
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Ankara Universitesi Teknokent
- Target Recruit Count
- 28
- Registration Number
- NCT04242719
- Locations
- 🇹🇷
Ankara University Biotechnology Institute, Ankara, Türkiye, Turkey
Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa
Not Applicable
Completed
- Conditions
- Retinitis Pigmentosa
- Interventions
- Biological: Platelet rich plasma
- First Posted Date
- 2020-01-23
- Last Posted Date
- 2020-01-23
- Lead Sponsor
- Ankara Universitesi Teknokent
- Target Recruit Count
- 48
- Registration Number
- NCT04238858
- Locations
- 🇹🇷
Ankara University Biotechnology Institute, Ankara, Türkiye, Turkey
Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser
Not Applicable
Completed
- Conditions
- Retinitis PigmentosaCystoid Macular Edema
- Interventions
- Device: SL-MPL treatment protocol was performed with a 577 nm yellow laser (EasyRet, Quantel Medical, Cedex, France)
- First Posted Date
- 2020-01-21
- Last Posted Date
- 2020-01-23
- Lead Sponsor
- Ankara Universitesi Teknokent
- Target Recruit Count
- 32
- Registration Number
- NCT04234438
- Locations
- 🇹🇷
Umut Arslan, Ankara, Türkiye, Turkey
🇹🇷Ankara University Biotechnology Institute, Ankara, Türkiye, Turkey
Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells
Phase 3
Completed
- Conditions
- Inherited Retinal DystrophyRetinitis Pigmentosa
- Interventions
- Biological: Wharton's jelly derived mesenchymal stem cell
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Ankara Universitesi Teknokent
- Target Recruit Count
- 32
- Registration Number
- NCT04224207
- Locations
- 🇹🇷
Umut Arslan, Ankara, Türkiye, Turkey
🇹🇷Ankara University Biotechnology Institute, Ankara, Türkiye, Turkey
Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasma
Not Applicable
Completed
- Conditions
- Central Serous ChorioretinopathyChronic Central Serous Chorioretinopathy
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Ankara Universitesi Teknokent
- Target Recruit Count
- 22
- Registration Number
- NCT04224831
- Locations
- 🇹🇷
Ankara University Biotechnology Institute, Ankara, Türkiye, Turkey
© Copyright 2025. All Rights Reserved by MedPath